Literature DB >> 11121150

Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans.

R R Müllegger1, G McHugh, R Ruthazer, B Binder, H Kerl, A C Steere.   

Abstract

Erythema migrans, the characteristic skin manifestation of acute Lyme borreliosis, is a self-limited lesion. In contrast, acrodermatitis chronica atrophicans, the typical cutaneous manifestation of late Lyme borreliosis, is a chronic skin condition. In an effort to understand pathogenic factors that lead to different outcomes in dermatoborrelioses, skin biopsy samples from 42 patients with erythema migrans and 27 patients with acrodermatitis chronica atrophicans were analyzed for mRNA expression of five pro-inflammatory cytokines (tumor necrosis factor alpha, interleukin-1 beta, interleukin-6, interferon-gamma, and interleukin-2) and two anti-inflammatory cytokines (interleukin-4 and interleukin-10) by in situ hybridization with cytokine-specific riboprobes. Among the 27 patients who had erythema migrans alone with no associated signs or symptoms, the major cytokines expressed in perivascular infiltrates of T cells and macrophages were the pro-inflammatory cytokine interferon-gamma and the anti-inflammatory cytokine interleukin-10. In the 15 erythema migrans patients who had associated signs and symptoms, including headache, elevated temperature, arthralgias, myalgias, or fatigue, a larger number of macrophages and greater expression of macrophage-derived pro-inflammatory cytokines, tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6, were also found. In comparison, infiltrates of T cells and macrophages in the skin lesions of acrodermatitis chronica atrophicans patients had very little or no interferon-gamma expression. Instead, they usually expressed only the pro-inflammatory cytokine tumor necrosis factor alpha and the anti-inflammatory cytokine interleukin-4. Thus, the activation of pro-inflammatory cytokines in erythema migrans lesions, particularly interferon-gamma, seems to be important in the control of the spirochetal infection. In contrast, the restricted pattern of cytokine expression in acrodermatitis chronica atrophicans, including the lack of interferon-gamma, may be less effective in spirochetal killing, resulting in the chronicity of this skin lesion. J Invest Dermatol 115:1115-1123 2000

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121150     DOI: 10.1046/j.1523-1747.2000.00198.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  32 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation.

Authors:  Aarti Gautam; Saurabh Dixit; Mario T Philipp; Shree R Singh; Lisa A Morici; Deepak Kaushal; Vida A Dennis
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 3.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

4.  Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.

Authors:  Klemen Strle; Junghee J Shin; Lisa J Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2012-05

5.  Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease.

Authors:  Klemen Strle; Kathryn L Jones; Elise E Drouin; Xin Li; Allen C Steere
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

6.  Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii.

Authors:  Klemen Strle; Elise E Drouin; Shiqian Shen; Joseph El Khoury; Gail McHugh; Eva Ruzic-Sabljic; Franc Strle; Allen C Steere
Journal:  J Infect Dis       Date:  2009-12-15       Impact factor: 5.226

7.  Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.

Authors:  Malte Bachmann; Katharina Horn; Ina Rudloff; Itamar Goren; Martin Holdener; Urs Christen; Nicole Darsow; Klaus-Peter Hunfeld; Ulrike Koehl; Peter Kind; Josef Pfeilschifter; Peter Kraiczy; Heiko Mühl
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

8.  Borrelia burgdorferi stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis.

Authors:  Junghee J Shin; Klemen Strle; Lisa J Glickstein; Andrew D Luster; Allen C Steere
Journal:  Arthritis Res Ther       Date:  2010-09-09       Impact factor: 5.156

9.  Inflammatory cytokine production predominates in early Lyme disease in patients with erythema migrans.

Authors:  Lisa Glickstein; Brian Moore; Tara Bledsoe; Nitin Damle; Vijay Sikand; Allen C Steere
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Borrelia infection and risk of non-Hodgkin lymphoma.

Authors:  Claudia Schöllkopf; Mads Melbye; Lars Munksgaard; Karin Ekström Smedby; Klaus Rostgaard; Bengt Glimelius; Ellen T Chang; Göran Roos; Mads Hansen; Hans-Olov Adami; Henrik Hjalgrim
Journal:  Blood       Date:  2008-04-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.